- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GPT Healthcare's 9MFY26 revenue climbed 12.12% YoY to INR 350.5 Cr, delivering EBITDA of INR 65.1 Cr (18.58% margin) and PAT of INR 27.6 Cr (7.89% margin). ARPOB reached INR 38,797; overall occupancy (ex-Raipur) was 55%.
Salt Lake and Agartala performed strongly, with Agartala adding oncology services. Dum Dum's restructuring reduced patient stay. Raipur's Q3 EBITDA loss was INR 2.5 Cr, but breakeven is expected in 6-8 months.
GPT targets a 1,000-bed network by 2027, with Jamshedpur (150 beds) commissioning Q4 FY27. Management remains positive on strategic expansion and achieving optimal occupancy at mature hospitals.